AZENTA INC (AZTA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AZTA • US1143401024

36.91 USD
-0.62 (-1.65%)
At close: Feb 3, 2026
36.91 USD
0 (0%)
After Hours: 2/3/2026, 6:02:29 PM
Fundamental Rating

5

AZTA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for AZTA as it has an excellent financial health rating, but there are worries on the profitability. AZTA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year AZTA was profitable.
  • In the past year AZTA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
  • Of the past 5 years AZTA 4 years had a positive operating cash flow.
AZTA Yearly Net Income VS EBIT VS OCF VS FCFAZTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.71%, AZTA is in line with its industry, outperforming 54.39% of the companies in the same industry.
  • The Return On Equity of AZTA (-3.23%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.71%
ROE -3.23%
ROIC N/A
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
AZTA Yearly ROA, ROE, ROICAZTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • With a Gross Margin value of 45.52%, AZTA perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
  • AZTA's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
AZTA Yearly Profit, Operating, Gross MarginsAZTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

8

2. Health

2.1 Basic Checks

  • AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AZTA has been increased compared to 1 year ago.
  • Compared to 5 years ago, AZTA has less shares outstanding
  • Compared to 1 year ago, AZTA has an improved debt to assets ratio.
AZTA Yearly Shares OutstandingAZTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AZTA Yearly Total Debt VS Total AssetsAZTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • AZTA has an Altman-Z score of 4.60. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.60, AZTA belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
  • The Debt to FCF ratio of AZTA is 0.04, which is an excellent value as it means it would take AZTA, only 0.04 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.04, AZTA belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that AZTA is not too dependend on debt financing.
  • The Debt to Equity ratio of AZTA (0.00) is better than 75.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 4.6
ROIC/WACCN/A
WACC11.08%
AZTA Yearly LT Debt VS Equity VS FCFAZTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • AZTA has a Current Ratio of 2.98. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
  • AZTA has a Current ratio of 2.98. This is comparable to the rest of the industry: AZTA outperforms 54.39% of its industry peers.
  • AZTA has a Quick Ratio of 2.66. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.66, AZTA perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.66
AZTA Yearly Current Assets VS Current LiabilitesAZTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

  • AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.27%, which is quite impressive.
  • Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
  • Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -9.52% in the last year.
  • AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
  • AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y51.12%
EPS Next 2Y39.62%
EPS Next 3Y33.99%
EPS Next 5Y27.49%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AZTA Yearly Revenue VS EstimatesAZTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
AZTA Yearly EPS VS EstimatesAZTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 69.64, the valuation of AZTA can be described as expensive.
  • AZTA's Price/Earnings is on the same level as the industry average.
  • AZTA is valuated expensively when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 46.08 indicates a quite expensive valuation of AZTA.
  • AZTA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 61.40% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.51, AZTA is valued quite expensively.
Industry RankSector Rank
PE 69.64
Fwd PE 46.08
AZTA Price Earnings VS Forward Price EarningsAZTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • AZTA's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 44.17
EV/EBITDA 33.4
AZTA Per share dataAZTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AZTA's earnings are expected to grow with 33.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y33.99%

0

5. Dividend

5.1 Amount

  • AZTA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AZENTA INC

NASDAQ:AZTA (2/3/2026, 6:02:29 PM)

After market: 36.91 0 (0%)

36.91

-0.62 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-21
Earnings (Next)02-04
Inst Owners111.91%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change11.23%
Market Cap1.69B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Analysts75.71
Price Target40.22 (8.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.43%
Min EPS beat(2)8.65%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)13.04%
Min EPS beat(4)-29.97%
Max EPS beat(4)37.26%
EPS beat(8)7
Avg EPS beat(8)70.99%
EPS beat(12)10
Avg EPS beat(12)146.49%
EPS beat(16)14
Avg EPS beat(16)123.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.95%
PT rev (1m)1.47%
PT rev (3m)22.67%
EPS NQ rev (1m)1.29%
EPS NQ rev (3m)-18.81%
EPS NY rev (1m)0.27%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 69.64
Fwd PE 46.08
P/S 2.85
P/FCF 44.17
P/OCF 23.45
P/B 0.98
P/tB 1.83
EV/EBITDA 33.4
EPS(TTM)0.53
EY1.44%
EPS(NY)0.8
Fwd EY2.17%
FCF(TTM)0.84
FCFY2.26%
OCF(TTM)1.57
OCFY4.26%
SpS12.95
BVpS37.66
TBVpS20.12
PEG (NY)1.36
PEG (5Y)N/A
Graham Number21.19
Profitability
Industry RankSector Rank
ROA -2.71%
ROE -3.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.52%
FCFM 6.45%
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0.02
Cap/Depr 55.31%
Cap/Sales 5.7%
Interest Coverage N/A
Cash Conversion 182.57%
Profit Quality N/A
Current Ratio 2.98
Quick Ratio 2.66
Altman-Z 4.6
F-Score5
WACC11.08%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
EPS Next Y51.12%
EPS Next 2Y39.62%
EPS Next 3Y33.99%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%
EBIT growth 1Y70.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year516.37%
EBIT Next 3Y105.69%
EBIT Next 5YN/A
FCF growth 1Y210.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.11%
OCF growth 3YN/A
OCF growth 5Y13.75%

AZENTA INC / AZTA FAQ

Can you provide the ChartMill fundamental rating for AZENTA INC?

ChartMill assigns a fundamental rating of 5 / 10 to AZTA.


What is the valuation status of AZENTA INC (AZTA) stock?

ChartMill assigns a valuation rating of 4 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.


How profitable is AZENTA INC (AZTA) stock?

AZENTA INC (AZTA) has a profitability rating of 2 / 10.


Can you provide the financial health for AZTA stock?

The financial health rating of AZENTA INC (AZTA) is 8 / 10.


How sustainable is the dividend of AZENTA INC (AZTA) stock?

The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.